1. Home
  2. WEA vs BDSX Comparison

WEA vs BDSX Comparison

Compare WEA & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Bond Fund Share of Beneficial Interest

WEA

Western Asset Bond Fund Share of Beneficial Interest

HOLD

Current Price

$10.85

Market Cap

130.2M

Sector

Finance

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.25

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEA
BDSX
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.2M
122.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
WEA
BDSX
Price
$10.85
$14.25
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
28.7K
71.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
7.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$10.16
$0.25
52 Week High
$11.44
$20.21

Technical Indicators

Market Signals
Indicator
WEA
BDSX
Relative Strength Index (RSI) 56.45 48.15
Support Level $10.65 $6.33
Resistance Level $10.85 $20.21
Average True Range (ATR) 0.14 1.22
MACD 0.05 -0.24
Stochastic Oscillator 83.61 35.06

Price Performance

Historical Comparison
WEA
BDSX

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: